Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ZNTL | Common Stock | Award | $0 | +102K | +34.22% | $0.00 | 400K | Feb 1, 2023 | Direct | F1, F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ZNTL | Stock Option (Right to Buy) | Award | $0 | +148K | $0.00 | 148K | Feb 1, 2023 | Common Stock | 148K | $23.65 | Direct | F3 |
Id | Content |
---|---|
F1 | Represents restricted stock units, each of which represent a contingent right to receive one share of common stock, and which will vest in substantially equal annual installments over a four year period following the grant date. |
F2 | Includes 399 shares acquired under the Zentalis Pharmaceuticals, Inc. 2020 Employee Stock Purchase Plan on March 31, 2022. |
F3 | The option vests and becomes exercisable in 48 substantially equal monthly installments following the grant date. |